Skip to content

Clinical trials

Terminated Phase 1/2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 1/2 Status: Terminated Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20063
20074
20083
20094
20102
20112
20121
20132
20142
20152
20171
20184
20202
20212
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center7
National Cancer Institute (NCI)3
Bellicum Pharmaceuticals2
Masonic Cancer Center, University of Minnesota2
Northwestern University2
Therapeutic Advances in Childhood Leukemia Consortium2
Washington University School of Medicine2
AO GENERIUM1
Abramson Cancer Center at Penn Medicine1
Astex Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma41
Leukemia17
Leukemia, Myeloid, Acute17
Lymphoma, Non-Hodgkin13
Myelodysplastic Syndromes13
Burkitt Lymphoma11
Lymphoma, Large B-Cell, Diffuse9
Lymphoma, Follicular8
Lymphoma, Large-Cell, Immunoblastic7
Lymphoma, Mantle-Cell7

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.